• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Pharmacokinetics of metoclopramide intravenously and orally determined by liquid chromatography.通过液相色谱法测定静脉注射和口服甲氧氯普胺的药代动力学。
Br J Clin Pharmacol. 1979 Nov;8(5):469-74. doi: 10.1111/j.1365-2125.1979.tb01028.x.
2
[Pharmacokinetics and bioequivalence of various oral formulations of metoclopramide].
Arzneimittelforschung. 1983;33(3):458-62.
3
The pharmacokinetics, bioequivalence and bioavailability of different formulations of metoclopramide in man.甲氧氯普胺不同制剂在人体中的药代动力学、生物等效性和生物利用度。
Arzneimittelforschung. 1981;31(6):1041-5.
4
The pharmacokinetics of metoclopramide in man with observations in the dog.甲氧氯普胺在人体的药代动力学及在犬类中的观察结果
Br J Clin Pharmacol. 1980 Apr;9(4):371-7. doi: 10.1111/j.1365-2125.1980.tb01064.x.
5
Analysis of formulation and food effect on the absorption of metoclopramide.
Int J Clin Pharmacol Ther. 2002 Apr;40(4):169-74. doi: 10.5414/cpp40169.
6
Pharmacokinetics and efficacy of high-dose metoclopramide given by continuous infusion for the control of cytotoxic drug-induced vomiting.持续输注高剂量胃复安控制细胞毒性药物所致呕吐的药代动力学及疗效
Br J Clin Pharmacol. 1984 Nov;18(5):679-84. doi: 10.1111/j.1365-2125.1984.tb02529.x.
7
Pharmacokinetic and concentration-effect studies with intravenous metoclopramide.静脉注射甲氧氯普胺的药代动力学和浓度-效应研究。
Br J Clin Pharmacol. 1978 Nov;6(5):401-7. doi: 10.1111/j.1365-2125.1978.tb04604.x.
8
Pharmacokinetics and bioavailability of the anti-emetic agent bromopride.止吐药溴必利的药代动力学和生物利用度
Biopharm Drug Dispos. 1986 May-Jun;7(3):215-22. doi: 10.1002/bdd.2510070302.
9
Pharmacokinetics of metoclopramide in patients with liver cirrhosis.肝硬化患者中甲氧氯普胺的药代动力学
Br J Clin Pharmacol. 1991 Feb;31(2):185-7. doi: 10.1111/j.1365-2125.1991.tb05511.x.
10
Clinical pharmacokinetics of metoclopramide.甲氧氯普胺的临床药代动力学
Clin Pharmacokinet. 1983 Nov-Dec;8(6):523-9. doi: 10.2165/00003088-198308060-00003.

引用本文的文献

1
Metoclopramide for analgesia in renal colic: a narrative systematic review.甲氧氯普胺在肾绞痛镇痛中的应用:叙述性系统评价。
BMC Urol. 2024 Nov 1;24(1):240. doi: 10.1186/s12894-024-01598-2.
2
Acquired long QT syndrome due to antiemetics, COVID-19 and induced exacerbation of congenital chloride losing diarrhoea.因止吐药、COVID-19 以及由此引发的先天性氯离子丢失性腹泻加重导致获得性长 QT 综合征。
BMJ Case Rep. 2022 Apr 26;15(4):e246175. doi: 10.1136/bcr-2021-246175.
3
Intravenous Metoclopramide to Improve the Success Rate of Blind Bedside Post-pyloric Placement of Feeding Tube in Critically Ill Children: A Randomized, Double-Blind, Placebo-Controlled Study.静脉注射甲氧氯普胺提高危重症儿童床边盲插幽门后置入喂养管成功率的随机双盲安慰剂对照研究
Front Pediatr. 2021 Dec 22;9:739247. doi: 10.3389/fped.2021.739247. eCollection 2021.
4
Influence of Cation Transporters (OCTs and MATEs) on the Renal and Hepatobiliary Disposition of [C]Metoclopramide in Mice.阳离子转运体(OCTs 和 MATEs)对[C]甲氧氯普胺在小鼠体内的肾和肝胆处置的影响。
Pharm Res. 2021 Jan;38(1):127-140. doi: 10.1007/s11095-021-03002-2. Epub 2021 Feb 8.
5
Metoclopramide-Induced Acute Dystonic Reactions May Be Associated With the CYP2D6 Poor Metabolizer Status and Pregnancy-Related Hormonal Changes.甲氧氯普胺诱导的急性肌张力障碍反应可能与CYP2D6代谢不良状态及妊娠相关激素变化有关。
Front Pharmacol. 2019 Aug 22;10:931. doi: 10.3389/fphar.2019.00931. eCollection 2019.
6
Positron Emission Tomography Imaging Reveals an Importance of Saturable Liver Uptake Transport for the Pharmacokinetics of Metoclopramide.正电子发射断层扫描成像显示,可饱和的肝脏摄取转运对甲氧氯普胺的药代动力学具有重要意义。
Contrast Media Mol Imaging. 2018 May 8;2018:7310146. doi: 10.1155/2018/7310146. eCollection 2018.
7
High pressure liquid chromatographic analysis of metoclopramide in serum.高效液相色谱法分析血清中灭吐灵。
Pharm Res. 1984 Jan;1(1):43-5. doi: 10.1023/A:1016334827197.
8
Risks and benefits of drugs used in the management of postoperative nausea and vomiting.用于术后恶心呕吐管理的药物的风险与益处。
Drug Saf. 1996 Mar;14(3):181-97. doi: 10.2165/00002018-199614030-00005.
9
The pharmacokinetics of metoclopramide in man with observations in the dog.甲氧氯普胺在人体的药代动力学及在犬类中的观察结果
Br J Clin Pharmacol. 1980 Apr;9(4):371-7. doi: 10.1111/j.1365-2125.1980.tb01064.x.
10
Single-dose pharmacokinetics of metoclopramide.甲氧氯普胺的单剂量药代动力学。
Eur J Clin Pharmacol. 1981;20(6):465-71. doi: 10.1007/BF00542101.

本文引用的文献

1
Assessment of pharmacokinetic constants from postinfusion blood curves obtained after I.V. infusion.通过静脉输注后获得的输注后血药浓度曲线评估药代动力学常数。
J Pharm Sci. 1970 Jan;59(1):53-5. doi: 10.1002/jps.2600590107.
2
Metoclopramide metabolism and determination by high-pressure liquid chromatography.甲氧氯普胺的代谢及高压液相色谱法测定
J Pharm Sci. 1977 Nov;66(11):1615-8. doi: 10.1002/jps.2600661128.
3
Pharmacokinetic and concentration-effect studies with metoclopramide [proceedings].
Br J Clin Pharmacol. 1977 Oct;4(5):650P. doi: 10.1111/j.1365-2125.1977.tb00822.x.
4
Metoclopramide: a review of its pharmacological properties and clinical use.甲氧氯普胺:其药理特性与临床应用综述
Drugs. 1976;12(2):81-131. doi: 10.2165/00003495-197612020-00001.
5
The effect of oral and intravenous metoclopramide on human lower esophageal sphincter pressure.
Gastroenterology. 1976 Apr;70(4):484-7.
6
Pharmacokinetic and concentration-effect studies with intravenous metoclopramide.静脉注射甲氧氯普胺的药代动力学和浓度-效应研究。
Br J Clin Pharmacol. 1978 Nov;6(5):401-7. doi: 10.1111/j.1365-2125.1978.tb04604.x.
7
Tardive dyskinesia associated with metoclopramide.与甲氧氯普胺相关的迟发性运动障碍。
Br Med J. 1978 Jan 14;1(6105):77-8. doi: 10.1136/bmj.1.6105.77.
8
CSTRIP, a fortran IV computer program for obtaining initial polyexponential parameter estimates.CSTRIP,一个用于获取初始多指数参数估计值的Fortran IV计算机程序。
J Pharm Sci. 1976 Jul;65(7):1006-10. doi: 10.1002/jps.2600650713.
9
Pharmacokinetics of metoclopramide.
Lancet. 1979 Jan 20;1(8108):166. doi: 10.1016/s0140-6736(79)90568-3.
10
The absorption and elimination of metoclopramide in three animal species.甲氧氯普胺在三种动物物种中的吸收与消除。
J Pharm Pharmacol. 1976 Jan;28(1):32-9. doi: 10.1111/j.2042-7158.1976.tb04019.x.

通过液相色谱法测定静脉注射和口服甲氧氯普胺的药代动力学。

Pharmacokinetics of metoclopramide intravenously and orally determined by liquid chromatography.

作者信息

Graffner C, Lagerström P O, Lundborg P, Rönn O

出版信息

Br J Clin Pharmacol. 1979 Nov;8(5):469-74. doi: 10.1111/j.1365-2125.1979.tb01028.x.

DOI:10.1111/j.1365-2125.1979.tb01028.x
PMID:508553
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1429814/
Abstract

1 A rapid and sensitive method, based on liquid chromatography, has been developed for determination of metoclopramide concentrations in plasma and urine samples. Concentrations down to 15 nmol/1 (5 ng/ml) of plasma and 100 nmol/1 (30 ng/ml) of urine could be determined with a relative standard deviation of less than or equal to 10%. The method was used to study disposition of metoclopramide in healthy volunteers following single doses intravenously and orally as aqueous solution and a slow release tablet. 2 The initial distribution after intravenous administration was very rapid. The elimination half-life postdistribution was 4.9 h. The apparent volume of distribution, Vd, was 3.0 1/kg body weight. On average 19% was excreted unchanged after intravenous administration of 5 and 10 mg (15 and 30 mumol) of drug. The rate of absorption of metoclopramide was delayed after administration of a slow release tablet and the maximum plasma concentration was about 50% lower than after a solution. The extent of bioavailability was the same following the two different formulations suggesting a first-pass elimination of 25-40%.

摘要
  1. 已开发出一种基于液相色谱的快速灵敏方法,用于测定血浆和尿液样本中的甲氧氯普胺浓度。血浆浓度低至15纳摩尔/升(5纳克/毫升)、尿液浓度低至100纳摩尔/升(30纳克/毫升)时均可测定,相对标准偏差小于或等于10%。该方法用于研究健康志愿者单次静脉注射、口服水溶液和缓释片后甲氧氯普胺的处置情况。2. 静脉给药后的初始分布非常迅速。分布后消除半衰期为4.9小时。表观分布容积Vd为3.0升/千克体重。静脉注射5毫克和10毫克(15和30微摩尔)药物后,平均19%以原形排泄。服用缓释片后,甲氧氯普胺的吸收速率延迟,最大血浆浓度比服用溶液后低约50%。两种不同制剂的生物利用度相同,表明首过消除率为25%-40%。